Cboe BZX Alternate has filed to record the Invesco Galaxy Solana ETF, aiming to supply regulated entry to SOL with built-in staking rewards, simply weeks after the primary U.S. Solana Staking ETF launched.
Invesco Galaxy Solana ETF Brings Spot Publicity
The Invesco Galaxy Solana ETF has been proposed to the U.S. Securities and Alternate Fee to be listed on Cboe BZX Alternate. The SEC submitting notes that the ETF is a commodity-based belief underneath BZX Rule 14.11.
The ETF would supply buyers direct publicity to the spot worth of Solana by holding precise SOL tokens. The belief may also stake a portion of its SOL holdings utilizing trusted suppliers, producing staking rewards. These rewards could also be handled as revenue for the fund.
If accredited, the Invesco Galaxy Solana ETF would develop into one of many earliest Solana spot ETFs obtainable in the USA. It follows the launch of the REX–Osprey Sol + Staking ETF (SSK), which started buying and selling on Cboe as the primary spot SOL ETF with staking assist.
Like SSK, the Invesco ETF is designed as a grantor belief and won’t register underneath the Funding Firm Act of 1940. It’s going to additionally not be regulated as a commodity pool. The ETF will use the Lukka Prime Solana Reference Fee to trace the asset’s worth.
The pricing information may also be refreshed each 15 seconds utilizing the information of the preferred exchanges, notably Binance, Coinbase, Kraken, and OKX. The sponsor shall be Invesco Capital Administration and administration and distribution shall be managed by Constancy.
Storing of the SOL within the fund shall be managed by a third-party custodian the place segregated and chilly wallets shall be used to make sure the perfect safety. The ETF will enable each money and in-kind creations and redemptions.
Cboe Cites SOL’s Market Integrity in ETF Bid to SEC
Cboe BZX argues within the submitting that Solana is immune to manipulation. The trade factors to SOL’s international 24/7 market, fragmented liquidity, and $2 billion common day by day buying and selling quantity.
It provides that the token’s decentralized design, arbitrage mechanisms, and lack of insider data additional cut back fraud dangers. This Solana ETF submitting depends on the identical regulatory logic utilized in earlier approvals for spot Bitcoin and Ethereum ETFs.
Cboe notes that Solana futures contracts started buying and selling on CME in March 2025 however haven’t but reached the “vital measurement” normal. The ETF will present regulated entry to Solana to buyers with out self-custody and publicity to offshore platform threat.
It’s going to additionally reduce monitoring errors witnessed in OTC merchandise of crypto. The step is a sign of an growing pattern towards making main altcoins extra accessible on American exchanges via ETF. SOL worth is at present $184.23, in line with CoinMarketCap information, down 1.3% within the final day.
Cboe Information to Listing First U.S. INJ ETF With Staking Rewards Function
Canary Staked INJ ETF has additionally been proposed by Cboe BZX Alternate for itemizing. This exchange-traded fund would supply direct publicity to the Injective (INJ) token, which governs the Injective Community.
In accordance with the submitting, the ETF would maintain precise INJ tokens and permit the sponsor to stake a portion to earn community rewards. These rewards could be handled as revenue for the fund. The ETF is designed to trace the CoinDesk INJ USD CCIX 60 min NY Fee.
Cboe notes that the U.S. INJ market has surpassed a $1.4 billion market cap as of July 2025. If accredited, this is able to be the primary INJ-based commodity belief ETF on a U.S. trade.
Funding disclaimer: The content material displays the writer’s private views and present market circumstances. Please conduct your individual analysis earlier than investing in cryptocurrencies, as neither the writer nor the publication is chargeable for any monetary losses.
Advert Disclosure: This website could characteristic sponsored content material and affiliate hyperlinks. All ads are clearly labeled, and advert companions haven’t any affect over our editorial content material.














✓ Share: